What is the recommended dose of Ceftriaxone for meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for Meningitis

For bacterial meningitis, the recommended dose of ceftriaxone is 2 grams IV every 12 hours (total 4 grams daily). 1, 2

Pathogen-Specific Dosing

  • For pneumococcal meningitis, administer ceftriaxone 2g IV every 12 hours for 10-14 days, with treatment extension if the patient has not recovered by day 10 1, 2
  • For meningococcal meningitis, administer ceftriaxone 2g IV every 12 hours for 5 days 1, 2
  • For Haemophilus influenzae meningitis, administer ceftriaxone 2g IV every 12 hours for 10 days 1, 2
  • For Enterobacteriaceae infections in CSF/blood, administer ceftriaxone 2g IV every 12 hours for 21 days 1

Special Considerations

  • For patients with suspected penicillin-resistant pneumococci, add vancomycin 15-20 mg/kg IV twice daily or rifampicin 600 mg twice daily to the ceftriaxone regimen 1, 2
  • For patients ≥60 years with suspected meningitis, add amoxicillin 2g IV every 4 hours to cover Listeria monocytogenes 1, 2
  • In pediatric patients with meningitis, the recommended dose is 100 mg/kg/day (not to exceed 4 grams daily), which may be administered once daily or divided every 12 hours 3
  • Treatment durations may need to be extended if the patient is not responding adequately to therapy 1

Administration Guidelines

  • Administer intravenous doses over 30 minutes in adults 3
  • In neonates, administer over 60 minutes to reduce the risk of bilirubin encephalopathy 3
  • Do not use diluents containing calcium, such as Ringer's solution or Hartmann's solution, to reconstitute ceftriaxone 3

Pharmacokinetic Considerations

  • Ceftriaxone penetrates well into the CSF, with mean trough levels of approximately 3.5 μg/mL 4
  • The high CSF penetration allows for effective treatment of meningitis, with cerebrospinal fluid bactericidal titers typically 1:128 or higher 4

Emerging Evidence

  • Recent research suggests that once-daily dosing (100 mg/kg/day) may achieve earlier pharmacodynamic targets compared to twice-daily dosing for common meningitis pathogens with MIC ≤1 mg/L 5
  • However, current guidelines still recommend twice-daily dosing for meningitis to ensure adequate CSF concentrations throughout the treatment period 1, 2
  • A 2023 study found no statistical difference in outcomes between once-daily (2g) and twice-daily (2g) ceftriaxone dosing regimens for penicillin-susceptible Streptococcus pneumoniae meningitis, suggesting that once-daily dosing may be sufficient for highly susceptible organisms 6

Common Pitfalls to Avoid

  • Do not underdose ceftriaxone for meningitis; the standard dose for other infections (1-2g daily) is insufficient for CNS infections 2
  • Do not delay treatment while waiting for culture results if bacterial meningitis is suspected 7
  • Do not discontinue therapy prematurely, even if clinical improvement occurs rapidly 7
  • For outpatient therapy of meningitis, ensure the patient has received at least 6 days of inpatient treatment, is afebrile for 24-48 hours, and is clinically improving 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A single daily dose of ceftriaxone for bacterial meningitis in adults: experience with 84 patients and review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Guideline

Duration of Treatment for Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.